Middle East Exosomes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments, Services), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

November 2025 | 120 pages | ID: MFA5A7C23EAFEN
Grand View Research, Inc.

Abstracts

The Middle East exosomes market size was estimated at USD 3.07 million in 2024 and is projected to reach USD 20.03 million by 2033, growing at a CAGR of 23.38% from 2025 to 2033. Exosomes, or Extracellular Vesicles (EVs), are single-membrane vesicles released by diverse cell types, and they are detected in multiple bodily fluids, including urine, plasma, saliva, breast milk, semen, cerebrospinal fluid (CSF), bronchial fluid, and amniotic fluid. These vesicles serve as carriers of proteins and genetic material, playing a critical role in intercellular communication and emerging as valuable tools in diagnostics and therapeutics.

Middle East Exosomes Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East exosomes market report based on product & service, workflow, application, end use, and country:

• Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
• Kits & Reagents
• Instruments
• Services
• Workflow Outlook (Revenue, USD Million, 2021 - 2033)
• Isolation Methods
• Ultracentrifugation
• Immunocapture on beads
• Precipitation
• Filtration
• Others
• Downstream Analysis
• Cell surface marker analysis using flow cytometry
• Protein analysis using blotting & ELISA
• RNA analysis with NGS & PCR
• Proteomic analysis using mass spectroscopy
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cancer
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostics Centers
• Academic & Research Institutes
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• Middle East
• Saudi Arabia
• UAE
• Kuwait
• Qatar
• Oman

Contents

CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Market Definitions
  1.2.1. Product & Service Segment
  1.2.2. Workflow Segment
  1.2.3. Application Segment
  1.2.4. End Use Segment
1.3. Information analysis
  1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
  1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

CHAPTER 3. EXOSOMES MARKET VARIABLES, TRENDS & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent market outlook
  3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
  3.2.1. Market driver analysis
    3.2.1.1. Growing adoption of exosome-based applications in diagnostics and therapeutics
    3.2.1.2. Increasing investment in biomedical and translational research
    3.2.1.3. Rising demand for liquid biopsy and non-invasive diagnostic technologies
  3.2.2. Market restraint analysis
    3.2.2.1. Stringent regulations pertaining to approval
    3.2.2.2. Challenges associated with implementation of exosome-based therapies
    3.2.2.3. High manufacturing and purification costs
3.3. Middle East Exosomes Market Analysis Tools
  3.3.1. Industry Analysis - Porter’s
  3.3.2. PESTEL Analysis

CHAPTER 4. MIDDLE EAST EXOSOMES MARKET: PRODUCT & SERVICE ESTIMATES & TREND ANALYSIS

4.1. Product & Services Segment Dashboard
4.2. Middle East Exosomes Market Product & Service Movement Analysis
4.3. Middle East Exosomes Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Kits & reagents
  4.4.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Instruments
  4.5.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Services
  4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

CHAPTER 5. MIDDLE EAST EXOSOMES MARKET: WORKFLOW ESTIMATES & TREND ANALYSIS

5.1. Workflow Segment Dashboard
5.2. Middle East Exosomes Market Workflow Movement Analysis
5.3. Middle East Exosomes Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
5.4. Isolation Methods
  5.4.1. Isolation methods market estimates and forecasts 2021 to 2033 (USD Million)
  5.4.2. Ultracentrifugation
    5.4.2.1. Ultracentrifugation market estimates and forecasts 2021 to 2033 (USD Million)
  5.4.3. Immunocapture on beads
    5.4.3.1. Immunocapture on beads market estimates and forecasts 2021 to 2033 (USD Million)
  5.4.4. Precipitation
    5.4.4.1. Precipitation market estimates and forecasts 2021 to 2033 (USD Million)
  5.4.5. Filtration
    5.4.5.1. Filtration market estimates and forecasts 2021 to 2033 (USD Million)
  5.4.6. Others
    5.4.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Downstream Analysis
  5.5.1. Downstream analysis market estimates and forecasts 2021 to 2033 (USD Million)
  5.5.2. Cell surface marker analysis using flow cytometry
    5.5.2.1. Cell surface marker analysis using flow cytometry market estimates and forecasts 2021 to 2033 (USD Million)
  5.5.3. Protein Analysis using blotting & ELISA
    5.5.3.1. Protein Analysis using blotting & ELISA market estimates and forecasts 2021 to 2033 (USD Million)
  5.5.4. RNA analysis with NGS & PCR
    5.5.4.1. RNA analysis with NGS & PCR market estimates and forecasts 2021 to 2033 (USD Million)
  5.5.5. Proteomic analysis using mass spectroscopy
    5.5.5.1. Proteomic analysis using mass spectroscopy market estimates and forecasts 2021 to 2033 (USD Million)
  5.5.6. Others
    5.5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

CHAPTER 6. MIDDLE EAST EXOSOMES MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

6.1. Application Segment Dashboard
6.2. Middle East Exosomes Market Application Movement Analysis
6.3. Middle East Exosomes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Cancer
  6.4.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Neurodegenerative Diseases
  6.5.1. Neurodegenerative diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Cardiovascular Diseases
  6.6.1. Cardiovascular diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Infectious Diseases
  6.7.1. Infectious diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Others
  6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

CHAPTER 7. MIDDLE EAST EXOSOMES MARKET: END USE ESTIMATES & TREND ANALYSIS

7.1. End Use Segment Dashboard
7.2. Middle East Exosomes Market End Use Movement Analysis
7.3. Middle East Exosomes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
  7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Hospitals & Diagnostics Centers
  7.5.1. Hospitals & diagnostics centers market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Academic & Research Institutes
  7.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)

CHAPTER 8. MIDDLE EAST EXOSOMES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS

8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Country Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. Middle East
  8.4.1. Middle East Exosomes Market, 2021 - 2033 (USD Million)
  8.4.2. Saudi Arabia
    8.4.2.1. Key Country Dynamics
    8.4.2.2. Competitive Scenario
    8.4.2.3. Regulatory Framework
    8.4.2.4. Saudi Arabia Exosomes Market, 2021 - 2033 (USD Million)
  8.4.3. UAE
    8.4.3.1. Key Country Dynamics
    8.4.3.2. Competitive Scenario
    8.4.3.3. Regulatory Framework
    8.4.3.4. UAE Exosomes Market, 2021 - 2033 (USD Million)
  8.4.4. Kuwait
    8.4.4.1. Key Country Dynamics
    8.4.4.2. Competitive Scenario
    8.4.4.3. Regulatory Framework
    8.4.4.4. Kuwait Exosomes Market, 2021 - 2033 (USD Million)
  8.4.5. Qatar
    8.4.5.1. Key Country Dynamics
    8.4.5.2. Competitive Scenario
    8.4.5.3. Regulatory Framework
    8.4.5.4. Qatar Exosomes Market, 2021 - 2033 (USD Million)
  8.4.6. Oman
    8.4.6.1. Key Country Dynamics
    8.4.6.2. Competitive Scenario
    8.4.6.3. Regulatory Framework
    8.4.6.4. Oman Exosomes Market, 2021 - 2033 (USD Million)

CHAPTER 9. COMPETITIVE LANDSCAPE

9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
  9.4.1. Bio-Techne Corporation
    9.4.1.1. Company overview
    9.4.1.2. Financial performance
    9.4.1.3. Product/Service benchmarking
    9.4.1.4. Strategic initiatives
  9.4.2. Danaher
    9.4.2.1. Company overview
    9.4.2.2. Financial performance
    9.4.2.3. Product/Service benchmarking
    9.4.2.4. Strategic initiatives
  9.4.3. Hologic Inc.
    9.4.3.1. Company overview
    9.4.3.2. Financial performance
    9.4.3.3. Product/Service benchmarking
    9.4.3.4. Strategic initiatives
  9.4.4. Fujifilm Holdings Corporation
    9.4.4.1. Company overview
    9.4.4.2. Financial performance
    9.4.4.3. Product/Service benchmarking
    9.4.4.4. Strategic initiatives
  9.4.5. Lonza
    9.4.5.1. Company overview
    9.4.5.2. Financial performance
    9.4.5.3. Product/Service benchmarking
    9.4.5.4. Strategic initiatives
  9.4.6. Miltenyi Biotec
    9.4.6.1. Company overview
    9.4.6.2. Financial performance
    9.4.6.3. Product/Service benchmarking
    9.4.6.4. Strategic initiatives
  9.4.7. QIAGEN
    9.4.7.1. Company overview
    9.4.7.2. Financial performance
    9.4.7.3. Product/Service benchmarking
    9.4.7.4. Strategic initiatives
  9.4.8. Thermo Fisher Scientific, Inc.
    9.4.8.1. Company overview
    9.4.8.2. Financial performance
    9.4.8.3. Product/Service benchmarking
    9.4.8.4. Strategic initiatives
  9.4.9. Abcam Plc
    9.4.9.1. Company overview
    9.4.9.2. Financial performance
    9.4.9.3. Product/Service benchmarking
    9.4.9.4. Strategic initiatives
  9.4.10. RoosterBio, Inc.
    9.4.10.1. Company overview
    9.4.10.2. Financial performance
    9.4.10.3. Product/Service benchmarking
    9.4.10.4. Strategic initiatives

List Of Tables

LIST OF TABLES


Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Middle East exosomes market, by country, 2021 - 2033 (USD Million)
Table 4 Middle East exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 5 Middle East exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 6 Middle East exosomes market, by application, 2021 - 2033 (USD Million)
Table 7 Middle East exosomes market, by end use, 2021 - 2033 (USD Million)
Table 8 Saudi Arabia exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 9 Saudi Arabia exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 10 Saudi Arabia exosomes market, by application, 2021 - 2033 (USD Million)
Table 11 Saudi Arabia exosomes market, by end use, 2021 - 2033 (USD Million)
Table 12 UAE exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 13 UAE exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 14 UAE exosomes market, by application, 2021 - 2033 (USD Million)
Table 15 UAE exosomes market, by end use, 2021 - 2033 (USD Million)
Table 16 Kuwait exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 17 Kuwait exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 18 Kuwait exosomes market, by application, 2021 - 2033 (USD Million)
Table 19 Kuwait exosomes market, by end use, 2021 - 2033 (USD Million)
Table 20 Qatar exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 21 Qatar exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 22 Qatar exosomes market, by application, 2021 - 2033 (USD Million)
Table 23 Qatar exosomes market, by end use, 2021 - 2033 (USD Million)
Table 24 Oman exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 25 Oman exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 26 Oman exosomes market, by application, 2021 - 2033 (USD Million)
Table 27 Oman exosomes market, by end use, 2021 - 2033 (USD Million)
Table 28 Participant’s overview
Table 29 Financial performance
Table 30 Key companies undergoing acquisitions
Table 31 Key companies undergoing collaborations & partnerships
Table 32 Key companies launching new products/services
Table 33 Key companies undertaking other strategies

List Of Figures

LIST OF FIGURES


Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Market segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Porter’s analysis
Fig. 13 PESTEL analysis
Fig. 14 Middle East exosomes market: Product & service outlook and key takeaways
Fig. 15 Middle East exosomes market: Product & service movement analysis
Fig. 16 Middle East kits & reagents market, 2021 - 2033 (USD Million)
Fig. 17 Middle East instruments market, 2021 - 2033 (USD Million)
Fig. 18 Middle East services market, 2021 - 2033 (USD Million)
Fig. 19 Middle East exosomes market: Workflow outlook and key takeaways
Fig. 20 Middle East exosomes market: Workflow movement analysis
Fig. 21 Middle East isolation methods market, 2021 - 2033 (USD Million)
Fig. 22 Middle East ultracentrifugation market, 2021 - 2033 (USD Million)
Fig. 23 Middle East immunocapture on beads market, 2021 - 2033 (USD Million)
Fig. 24 Middle East precipitation market, 2021 - 2033 (USD Million)
Fig. 25 Middle East filtration market, 2021 - 2033 (USD Million)
Fig. 26 Middle East other isolation methods market, 2021 - 2033 (USD Million)
Fig. 27 Middle East downstream analysis market, 2021 - 2033 (USD Million)
Fig. 28 Middle East cell surface marker analysis using flow cytometry market, 2021 - 2033 (USD Million)
Fig. 29 Middle East protein analysis using blotting & ELISA market, 2021 - 2033 (USD Million)
Fig. 30 Middle East RNA analysis with NGS & PCR market, 2021 - 2033 (USD Million)
Fig. 31 Middle East proteomic analysis using mass spectroscopy market, 2021 - 2033 (USD Million)
Fig. 32 Middle East other downstream analysis market, 2021 - 2033 (USD Million)
Fig. 33 Middle East exosomes market: Application outlook and key takeaways
Fig. 34 Middle East exosomes market: Application movement analysis
Fig. 35 Middle East cancer market, 2021 - 2033 (USD Million)
Fig. 36 Middle East neurodegenerative diseases market, 2021 - 2033 (USD Million)
Fig. 37 Middle East cardiovascular diseases market, 2021 - 2033 (USD Million)
Fig. 38 Middle East infectious diseases market, 2021 - 2033 (USD Million)
Fig. 39 Middle East other applications market, 2021 - 2033 (USD Million)
Fig. 40 Middle East exosomes market: End Use outlook and key takeaways
Fig. 41 Middle East exosomes market: End Use movement analysis
Fig. 42 Middle East pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
Fig. 43 Middle East hospitals & diagnostics centers market, 2021 - 2033 (USD Million)
Fig. 44 Middle East academic & research institutes market, 2021 - 2033 (USD Million)
Fig. 45 Middle East exosomes market: Regional outlook and key takeaways
Fig. 46 Middle East exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 47 Saudi Arabia key country dynamics
Fig. 48 Saudi Arabia exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 49 UAE key country dynamics
Fig. 50 UAE exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 51 Kuwait key country dynamics
Fig. 52 Kuwait exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 53 Qatar key country dynamics
Fig. 54 Qatar exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 55 Oman key country dynamics
Fig. 56 Oman exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 57 Market participant categorization
Fig. 58 Middle East exosomes market position analysis, 2024
Fig. 59 Strategy framework